Cystic Fibrosis
Research from California State University yields new findings on cystic fibrosis
Published in Pharma Law Weekly, June 2nd, 2009
According to recent research published in the Biochemical Journal, "Antimicrobial polypeptides, including lysozymes, have membrane perturbing activity and are well-documented effector molecules of innate immunity. In cystic fibrosis, a hereditary disease with frequent lung infection with Pseudomonas aeruginosa, the non-esterified fatty acid DA (docosahexaenoic acid), but not OA (oleic acid), is decreased, and DA supplementation has been shown to improve the clinical condition in these patients."
"We hypothesized that DA may, either alone or in conjunction with lysozyme, exert antibacterial action against Ps. aeruginosa. We found that DA anti lysozyme...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Law Weekly
Source: Pharma Law Weekly (2009-06-02)
More Articles from Pharma Law Weekly
- Allied Security Innovations, Inc.
Allied Security Innovations Publishes Promising Financial Information - AmberPoint, Inc.
AmberPoint Delivers More Comprehensive Governance Capabilities for Heterogeneous Environments that Include SAP NetWeaverŽ - American Federation of Government Employees
Need for Collective Bargaining Evident as TSA Again Lands Bottom Spot of Best Places to Work - American Financial Services Association Education Foundation
Emergency Preparations Should Include Finances, Too - American Policy Roundtable
Roundtable Calls on President Obama to Save Chrysler Jobs - American Public Health Association
APHA Joins National Coalition in Issuing Transportation Reform Blueprint - More from this issue of Pharma Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
